Report on HIV/AIDS from IDSA: news from the mile high city. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Report on HIV/AIDS from IDSA: news from the mile high city.

Hopkins HIV Rep. 1999 Jan;11(1):1, 4, 7. Unique Identifier : AIDSLINE AIDS/20700021
Bartlett JG


Abstract: HIV/AIDS was the subject of some of the presentations at the annual meeting of the Infectious Diseases Society of America (ISDA). The most significant presentation was by Dr. Anthony Fauci, who described the possibility of using IL-2 to purge latently-infected CD4 cells. Other presentations covered treatment of primary HIV infection, updates on developments of nucleoside inhibitors, an efavirenz (EFV) update, PCP prophylaxis, care delivery options, and co-infection with tuberculosis.


Keywords: NEWSLETTER ARTICLE CONGRESSES AIDS-Related Opportunistic Infections/*PREVENTION & CONTROL Anti-HIV Agents/*THERAPEUTIC USE Colorado Dideoxynucleosides/THERAPEUTIC USE Drug Interactions Drug Therapy, Combination HIV Infections/*DRUG THERAPY/IMMUNOLOGY Human Interleukin-2/*THERAPEUTIC USE Oxazines/THERAPEUTIC USE Physician's Practice Patterns Pneumonia, Pneumocystis carinii/PREVENTION & CONTROL Reverse Transcriptase Inhibitors/THERAPEUTIC USE Tuberculosis/PREVENTION & CONTROL United States

KWDnewsletterarticlecongressesaids-relatedopportunisticinfections/KWDprevention&controlanti-hivagents/KWDtherapeuticusecoloradodideoxynucleosides/therapeuticusedruginteractionsdrugtherapy,combinationhivinfections/KWDdrugtherapy/immunologyhumaninterleukin-2/KWDtherapeuticuseoxazines/therapeuticusephysician'spracticepatternspneumonia,pneumocystiscarinii/prevention&controlreversetranscriptaseinhibitors/therapeuticusetuberculosis/prevention&controlunitedstates
000330
A0030928


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .